Institutional development · Research, innovation and assessment · Mexico
Toronto and Singapore researchers present organ-on-a-chip work at Tec de Monterrey congress
Researchers from the University of Toronto and the National University of Singapore presented organ-on-a-chip work at Biofabrication 2026, held on Tec de Monterrey's Monterrey campus from 2 to 6 November.
Why it matters: Researchers from the University of Toronto and the National University of Singapore presented organ-on-a-chip advances for disease study and drug testing at Tec de Monterrey's congress.
Tecnológico de Monterrey said the international congress Biofabrication 2026 took place on its Monterrey campus from 2 to 6 November.
According to the university, organ-on-a-chip platforms are cell-culture devices intended to reproduce human organ conditions and functions at small scale so that diseases can be studied and medicines tested.
Milica Radisic of the University of Toronto, who the university says has simulated cardiac tissue and created functional blood vessels, presented a model called Engineering Vascularized Organs-on-a-Chip aimed at improving drug discovery and reducing clinical risks.
Lim Chwee Teck of the National University of Singapore, who studies how physical forces affect cell behaviour and regeneration, also presented advances in the field at the congress.
Editor’s view
Scott James, Research and Innovation Editor
Tec de Monterrey's Monterrey campus hosted Biofabrication 2026 from 2 to 6 November, where a University of Toronto researcher presented a vascularised organ-on-a-chip model intended to improve drug discovery and reduce clinical risks.
